Efficacy and safety of mesalamine suppos
β
Melvin B. Heyman; Jaroslaw Kierkus; Jean SpΓ©nard; Hadia Shbaklo; Monique Giguere
π
Article
π
2010
π
John Wiley and Sons
π
English
β 148 KB
Background: Treatment of ulcerative proctitis has not been well studied in pediatric populations. We conducted an open-label trial to evaluate the clinical efficacy of a mesalamine suppository (500 mg) to treat pediatric patients with mild to moderate ulcerative proctitis. Methods: Pediatric patien